RxDoctor Payments Data

Scott Schulman, DPM

Podiatrist · Indianapolis, INNPI 1184625972

Payments from drug & device makers

$799in general payments, 2019–2025

Across 11 payments — averaging $72.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$304
  • Trilliant Surgical LLC.$155
  • DJO, LLC$151
  • Heron Therapeutics, Inc.$110
  • Zimmer Biomet$21
  • Miromatrix Medical Inc.$19
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$64981%
  • Other$15119%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker3$304
Trilliant Surgical LLC.1$155
DJO, LLC1$151
Heron Therapeutics, Inc.1$110
Zimmer Biomet1$21
Miromatrix Medical Inc.1$19
Celularity Inc.1$14
Boston Scientific1$14
Merck1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$799 in reported general payments places this provider in the 40th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$106,881
Medicare patients
350
Services billed
2,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam17$31

Paid to pharmacies, not to this prescriber.

Other podiatrist in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →